HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Mori Selected Research

Biomarkers (Surrogate Marker)

1/2021A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease.
7/2018Cross-Sectional Inverse Association of Regular Soy Intake with Insulin Resistance in Japanese Elderly.
8/2002Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
4/2000Tau protein is a potential biological marker for normal pressure hydrocephalus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Mori Research Topics

Disease

28Neoplasms (Cancer)
01/2020 - 01/2000
25Carcinogenesis
01/2004 - 01/2000
14Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2000
13Body Weight (Weight, Body)
09/2001 - 02/2000
8Ischemia
05/2008 - 02/2000
8Aberrant Crypt Foci
08/2002 - 01/2000
7Infarction (Infarctions)
08/2003 - 08/2000
6Infections
02/2014 - 02/2000
5Carcinoma (Carcinomatosis)
01/2008 - 07/2000
4Colorectal Neoplasms (Colorectal Cancer)
02/2009 - 01/2000
4Reperfusion Injury
05/2008 - 01/2001
4Amyloid Plaque
11/2002 - 09/2000
4Pain (Aches)
08/2001 - 01/2000
3Fibrosis (Cirrhosis)
01/2020 - 12/2000
3Type 2 Diabetes Mellitus (MODY)
05/2013 - 04/2001
3Adenoma (Adenomas)
01/2013 - 06/2001
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2012 - 10/2000
3Hypoxia (Hypoxemia)
05/2008 - 06/2000
3Wounds and Injuries (Trauma)
05/2008 - 11/2000
3Endometrial Neoplasms (Endometrial Cancer)
03/2005 - 01/2000
3Heart Failure
12/2001 - 08/2001
3Parkinsonian Disorders (Parkinsonism)
10/2001 - 02/2001
3Hyperalgesia
08/2001 - 01/2000
3Colonic Neoplasms (Colon Cancer)
06/2001 - 11/2000
3Dementia (Dementias)
04/2001 - 01/2000
3Necrosis
10/2000 - 01/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 01/2003
2Insulin Resistance
07/2018 - 02/2000
2Cardiovascular Diseases (Cardiovascular Disease)
07/2018 - 01/2001
2Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 01/2008
2Lymphoma (Lymphomas)
02/2015 - 10/2001
2Ulcer
01/2014 - 07/2012
2Pneumonia (Pneumonitis)
08/2012 - 12/2010
2Bronchiectasis
03/2011 - 03/2009
2Encephalitis (Encephalitis, Rasmussen)
12/2010 - 10/2003
2Coronary Occlusion
05/2008 - 10/2001
2Myocardial Ischemia (Ischemic Heart Diseases)
05/2008 - 10/2000
2Hepatocellular Carcinoma (Hepatoma)
06/2005 - 11/2000
2Shock
01/2005 - 11/2004
2Dyspnea (Shortness of Breath)
07/2004 - 07/2000
2Acidosis
09/2002 - 09/2001
2Adenocarcinoma
12/2001 - 07/2001
2Corticobasal Degeneration
11/2001 - 03/2000
2Parkinson Disease (Parkinson's Disease)
10/2001 - 05/2001

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2004 - 01/2000
7beta CateninIBA
08/2002 - 07/2000
6AzoxymethaneIBA
09/2001 - 01/2000
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2005 - 01/2000
5Amyloid beta-PeptidesIBA
11/2002 - 01/2000
5CarcinogensIBA
08/2002 - 07/2000
5Estrogens (Estrogen)FDA Link
09/2001 - 01/2000
4Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2000
4Amyloid (Amyloid Fibrils)IBA
01/2021 - 01/2000
4Peroxidase (Myeloperoxidase)IBA
04/2017 - 09/2000
4Messenger RNA (mRNA)IBA
02/2009 - 03/2000
4Biological ProductsIBA
09/2003 - 08/2000
4cytidylyl-(3'-5')-cytidine (CpC)IBA
11/2001 - 03/2000
4Presenilin-1IBA
07/2001 - 01/2000
3Hormones (Hormone)IBA
01/2020 - 01/2001
3Pharmaceutical PreparationsIBA
07/2018 - 05/2001
3DNA (Deoxyribonucleic Acid)IBA
06/2009 - 02/2000
3AntibodiesIBA
12/2001 - 10/2000
3CurcuminIBA
09/2001 - 09/2000
3Capsaicin (Zostrix)FDA Link
08/2001 - 01/2000
3ferric oxide (iron oxide)IBA
12/2000 - 07/2000
3nitrosobenzylmethylamineIBA
09/2000 - 02/2000
2SaltsIBA
07/2018 - 09/2011
2IsoflavonesIBA
07/2018 - 07/2001
2PotassiumIBA
07/2018 - 06/2000
2Antipsychotic Agents (Antipsychotics)IBA
01/2017 - 05/2001
2Hyaluronic Acid (Hyaluronan)IBA
12/2016 - 05/2001
2SteroidsIBA
07/2012 - 10/2001
2CytokinesIBA
06/2009 - 07/2001
2Dialysis SolutionsIBA
05/2008 - 10/2001
2Contrast MediaIBA
05/2007 - 07/2000
2Glutamate Receptors (Glutamate Receptor)IBA
10/2003 - 03/2001
2EpitopesIBA
10/2003 - 08/2001
2N-Methylaspartate (NMDA)IBA
10/2003 - 03/2001
2SolutionsIBA
09/2003 - 04/2001
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2003 - 03/2000
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2003 - 06/2001
2Adenosine Triphosphate (ATP)IBA
09/2002 - 01/2001
2GhrelinIBA
12/2001 - 09/2001
2Methylnitronitrosoguanidine (MNNG)IBA
09/2001 - 09/2001
2juzentaihotoIBA
09/2001 - 04/2001
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2001 - 03/2000
2Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
09/2001 - 04/2001
21'-acetoxychavicol acetateIBA
09/2001 - 02/2000

Therapy/Procedure

6Therapeutics
01/2019 - 07/2000
3Surgical Instruments (Clip)
01/2014 - 07/2012
3Traction
01/2013 - 03/2009
3Synchrotrons
05/2007 - 10/2000
3Injections
07/2000 - 02/2000
2Adjuvant Chemotherapy
01/2017 - 01/2008
2Transplantation
02/2015 - 04/2005
2Aftercare (After-Treatment)
03/2009 - 11/2000
2Drug Therapy (Chemotherapy)
01/2008 - 02/2001
2Intravenous Administration
11/2004 - 01/2001
2Chemoprevention
08/2002 - 09/2001
2Subcutaneous Injections
09/2001 - 01/2000